English
Back
Download
Log in to access Online Inquiry
Back to the Top

Institutions are buying quietly.

$Vir Biotechnology (VIR.US)$ Only fools would sell. I added it to the risk control limit, it's a pity. The company's pipeline alone is worth 30-50. The existing order is worth 5 yuan. GSK can easily add another 5 yuan with any deal.
The current approach is to discuss the acquisition. Estimated acquisition at 70?
GSK took 20K in Canada. Multiply by 2100. 41M, sigh...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
See Original
Report
14K Views
Comment
Sign in to post a comment
个人投资观点。没有FINRA执照,不代表供职的机构或客户(反正我看不到)。不提供投资建议。临时改个名,免得被citadel找麻烦
285
Followers
20
Following
1984
Visitors
Follow